Improving detection and prediction of cognitive changes in multiple sclerosis using new assessment methods
Optimizing detection and prediction of changes in cognitive function in multiple sclerosis with novel ambulatory assessment methods
This study is looking at how multiple sclerosis affects thinking and memory by using a special smartphone app that lets people take cognitive tests in their daily lives, helping us learn more about the challenges they face.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-10892668 on NIH RePORTER |
What this research studies
This research focuses on understanding cognitive dysfunction in individuals with multiple sclerosis (MS) by utilizing innovative technology-assisted methods. Participants will engage with a customized smartphone app that administers cognitive tests in their everyday environments, allowing for real-time assessment of cognitive function. The study aims to identify patterns and factors that contribute to cognitive decline, ultimately enhancing our understanding of how MS affects daily life. By employing multiple assessment strategies, the research seeks to fill existing gaps in knowledge regarding cognitive impairment in MS.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with multiple sclerosis who experience cognitive dysfunction.
Not a fit: Patients without a diagnosis of multiple sclerosis or those who do not experience cognitive issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved methods for detecting and predicting cognitive changes in patients with multiple sclerosis, enhancing their quality of life.
How similar studies have performed: Previous research has shown promise in using technology-assisted assessments for cognitive evaluation, indicating potential success for this novel approach.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Kratz, Anna Louise — University of Michigan at Ann Arbor
- Study coordinator: Kratz, Anna Louise
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.